Zoetis Backslides After Spiking On Valeant Approach

By | June 26, 2015

Scalper1 News

Shares of Zoetis (ZTS) are backsliding Friday following a 11.4% surge the day before on talk that Valeant was eyeing the animal-health company. Zoetis shares plummeted 9.7% to 50.01 in the stock market today. Activist investor Bill Ackman’s hedge fund, Pershing Square, is the company’s largest shareholder, with an 8.5% stake. Valeant Pharmaceuticals (VRX) reportedly made a preliminary approach to acquire the animal-health company, said the Wall Scalper1 News

Scalper1 News